Detection of low numbers of bacterial cells in a pharmaceutical drug product using Raman spectroscopy and PLS-DA multivariate analysis

Rubén Adrián Grosso*, Anders Runge Walther, Ellen Brunbech, Anders Sørensen, Brian Schebye, Katharina Olsen, Haiyan Qu, Martin Aage Barsøe Hedegaard, Eva C. Arnspang*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

141 Downloads (Pure)

Abstract

Sterility testing is a laborious and slow process to detect contaminants present in drug products. Raman spectroscopy is a promising label-free tool to detect microorganisms and thus gaining relevance as a future alternative culture-free method for sterility testing in the pharmaceutical industry. However, reaching detection limits similar to standard procedures while keeping a high accuracy remains challenging, due to weak bacterial Raman signals. In this work, we show a new non-invasive approach focusing on detection of different bacteria in concentrations below 100 CFU per ml within drug product containers using Raman spectroscopy and multivariate data analysis. Even though Raman spectra from drug product with and without bacteria are similar, a partial least squared discriminant analysis (PLS-DA) model shows great performance to distinguish samples with bacterial contaminants in concentrations down to 10 CFU per ml. We used spiked samples with bacterial spores for model validation achieving a detection accuracy of 99%. Our results indicate the great potential of this rapid, and cost-effective approach to be used in quality control in the pharmaceutical industry.

Original languageEnglish
JournalAnalyst
Volume147
Issue number15
Pages (from-to)3593-3603
ISSN1364-5528
DOIs
Publication statusPublished - 7. Aug 2022

Fingerprint

Dive into the research topics of 'Detection of low numbers of bacterial cells in a pharmaceutical drug product using Raman spectroscopy and PLS-DA multivariate analysis'. Together they form a unique fingerprint.

Cite this